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ORIGINAL ARTICLE
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Background: Patients with Barrett’s oesophagus (BO) are at risk of oesophageal adenocarcinoma.
Because the pattern of mucosal mucins changes during neoplastic progression, it may serve as a marker of
intraepithelial neoplasia.
Aims: To determine the expression pattern of mucins in neoplastic BO epithelium (high grade dysplasia)
and correlate it with the expression of apoptosis markers Bax and Bcl-2.
Methods: Thirty seven patients with BO were studied: 16 without intraepithelial neoplasia, six with high
grade intraepithelial neoplasia (HGN), and 15 with infiltrating adenocarcinoma. Biopsies were obtained
from squamous epithelium, Barrett’s epithelium, and (when present) foci of suspected HGN or
adenocarcinoma. MUC1–4, MUC5AC, MUC5B, MUC6, Bax, and Bcl-2 mRNA were determined by
semiquantitative RT-PCR. MUC2, MUC5AC, and MUC6 protein was determined by immunoblotting.
Results: Mucin expression varied between neoplastic progression stages in BO. Mucin mRNA levels were
low in squamous epithelium, except for MUC4, and were at least four times higher in BO and HGN
(p,0.001), but less so in adenocarcinoma. MUC4 expression was significantly lower in BO than in
normal squamous epithelium, whereas in HGN and adenocarcinoma, levels were significantly higher than
in BO (p = 0.037). The Bax:Bcl-2 ratio was increased in HGN compared with BO (p = 0.04). MUC2,
MUC5AC, and MUC6 protein values correlated with mRNA data.
Conclusions: Mucin expression varies during the development of oesophageal adenocarcinoma in BO.
MUC4 could serve as a tumour marker in this process. In contrast to animal studies, upregulation of MUC4
in HGN is associated with increased apoptosis, suggesting that MUC4 plays a minor role in apoptosis
regulation in BO.
B
arrett’s oesophagus (BO) is a premalignant condition in
which the normal squamous epithelium of the lower
oesophagus is replaced by specialised columnar epithe-
lium. Gastro–oesophageal reflux is believed to play an
important role in the aetiology of BO.1 2 Adenocarcinoma
(ADC) is thought to develop in BO in a stepwise manner, via
low grade intraepithelial neoplasia and high grade intra-
epithelial neoplasia (HGN).3 ADC has a poor prognosis,
because metastasis occurs early and symptoms present late in
the course of the disease. The overall five year survival is only
10–15%.4
‘‘Markers that indicate the presence of high grade
intraepithelial neoplasia could be helpful in the identifica-
tion of patients at risk of malignant transformation’’
Early detection of malignant progression is the key factor
for improving the outcome of oesophageal ADC. Current
guidelines recommend endoscopic surveillance to detect
intraepithelial neoplasia (often referred to as dysplasia) and
to diagnose carcinoma at an early treatable stage.5 However,
the efficacy of endoscopic surveillance is thwarted by several
factors.6 Sampling error can occur in endoscopic random
biopsy sampling.7 In addition, a correct pathological diag-
nosis of intraepithelial neoplasia is difficult and focal
neoplastic changes can easily be missed in small biopsy
samples. This is reflected by a considerable interobserver and
intraobserver variability among pathologists in the inter-
pretation of epithelial changes in BO.8
The use of molecular markers in addition to normal
endoscopical and histological evaluation could significantly
enhance the detection of neoplasia in BO, both in vitro and in
vivo. In particular, markers that indicate the presence of HGN
could be helpful in the identification of patients at risk of
malignant transformation.
Mucins are large glycoproteins that are the main compo-
nents of the gel-like mucous layer on the surface of the
intestine. This layer serves to protect the mucosa from
mechanical damage. Each type of mucosa has a unique
pattern of mucin expression, and this pattern changes during
neoplastic progression. Therefore, mucins are putative mole-
cular markers for the development of adenocarcinoma in BO.
Currently, more than 10 MUC genes have been reported, the
best characterised being MUC1–4, MUC5AC, MUC5B, and
MUC6. Of these, only MUC1 and MUC4 are expressed in the
normal squamous lining of the oesophagus,9 whereas BO
predominantly expresses MUC2, and to a lesser extent
MUC5AC and MUC6.10–12
In addition to protection against mechanical damage,
membrane bound mucins MUC1 and MUC4 have also been
reported to be involved in oncogenic pathways. MUC1 can
bind to b catenin, thereby altering its ability to bind to
E-cadherin, which leads to decreased cell–cell adhesion and
Abbreviations: ADC, adenocarcinoma; AP, alkaline phosphatase; BO,
Barrett’s oesophagus; HGN, high grade intraepithelial neoplasia; PCR,
polymerase chain reaction; RT, reverse transcription
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uncontrolled proliferation.13 14 MUC4, a mucin that is
upregulated in several tumour types, acts as a ligand for
the receptor tyrosine kinase, Erb-B2, thereby regulating the
p27kip cell cycle inhibitor.15 MUC4 also inhibits apoptosis in a
xenotransplanted melanoma model in nude mice.16
The aim of our study was to evaluate the expression
patterns of MUC1–4, MUC5AC, MUC5B, and MUC6 in high
grade intraepithelial neoplasia and adenocarcinomas in BO,
and to determine the association with the apoptosis markers
Bax and Bcl-2.
METHODS
Patients
In total, 37 patients with BO were studied. Sixteen patients
had BO without intraepithelial neoplasia, six patients had BO
with high grade intraepithelial neoplasia, and 15 had an
infiltrating adenocarcinoma. Patients were evaluated by
standard oesophagoscopy and high magnification chromen-
doscopy. Biopsies were obtained from the squamous epithe-
lium, Barrett’s epithelium, and (when present) from foci of
suspected high grade intraepithelial neoplasia or adenocarci-
noma. Two expert gastrointestinal pathologists indepen-
dently evaluated haematoxylin and eosin stained sections
for the presence of BO, grade of intraepithelial neoplasia,
and ADC. All patients diagnosed with high grade intra-
epithelial neoplasia routinely underwent endomucosal
resection. Endomucosal resection specimens were indepen-
dently analysed by two pathologists to ensure that there
were no indications for the presence of an (infiltrating)
adenocarcinoma. Ten patients with adenocarcinoma were
treated surgically and five patients received palliative
treatment. All adenocarcinomas had infiltrated into the
submucosa and three patients had local lymph node
metastases. Eight tumours were well differentiated and
seven were poorly differentiated. Our study was approved
by the ethical committee of the Erasmus MC Rotterdam, The
Netherlands, and informed consent was obtained before
endoscopy.
RNA and protein isolation from biopsies
Biopsies were snap frozen in liquid nitrogen. Total RNA was
isolated using TRIzol reagent (Invitrogen, Groningen, The
Netherlands), according to the manufacturer’s instructions.
The remaining chromosomal DNA was removed with the
RNA free DNA kit (Zymo, Orange, California, USA). Total
RNA concentrations were estimated by RNA electrophoresis
on an agarose gel and band intensity was compared with that
of a marker band with a known concentration. From the
same biopsy specimen, a protein fraction was isolated
according to the manufacturer’s instructions and denatured
in 1% sodium dodecyl sulfate. Protein concentrations were
determined with the BCA protein assay kit (Pierce, Rockford,
Illinois, USA).
Reverse transcriptase polymerase chain reaction
cDNA was synthesised with the use of avian myeloma virus
reverse transcriptase (RT; Promega, Madison, Wisconsin,
USA). Primers were annealed by cooling down from 70 C˚ to
room temperature. cDNA was synthesised by incubation of
the mRNA for 30 minutes at 42 C˚. Polymerase chain reactions
(PCRs) (total volume of 25 ml) contained 1 ml of the cDNA
solution, 16 PCR core buffer (Promega), 2mM magnesium
Table 1 Polymerase chain reaction primers
Amplified gene Forward primer Reverse primer
MUC1 59TGCATCAGGCTCAGCTTCTA39 59ACGTCGTGGACATTGATGGT39
MUC2 59CAGGATGGCGCCTTCTGCTA39 59A´TGCTGCTCCAAGCTGAGGT39
MUC3 59CCAGCCAGGATGTGAACAG39 59GACAGTCGATGGCGTTGTC39
MUC4 59TCAACGCCTCGGTGGCATAC39 59CTGTCACATCGCGCACGTCT39
MUC5B 59TTGACGGCACCTCTTACACC39 59GCCTGGAAGACTTGGCCATT39
MUC5AC 59CCGGAGGTGAACATTGAAC 39 59TCTGTGGCGGTATATGGTG39
MUC6 59GCAGGAGGAGATCACGTTCA39 59CGCCTCCTCTGTGGCTTCAT39
Bax 59GGCCCACCAGCTCTGAGCAGA39 59GCCACGTGGGCGTCCCAAAGT39
Bcl-2 59GTGGAGGAGCTCTTCAGGGA39 59A´GGCACCCAGGGTGATGCAA39
b actin 59GACAGGATGCAGAAGGAGAT39 59AGTCATAGTCCGCCTAGAAG39
Figure 1 Representative examples of reverse transcriptase polymerase
chain reaction (RT-PCR) results. mRNA of MUC1, MUC2, MUC3, MUC4,
MUC5AC, MUC5B, and MUC6 in squamous epithelium (Sq), Barrett’s
oesophagus (BO), and adenocarcinoma (ADC). mRNA was isolated
from biopsy samples of a patient with BO containing HGN and ADC.
b Actin was used as a control for RNA input. PCR products were
analysed on a 1% agarose gel containing ethidium bromide.
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chloride, 0.4mM forward and reverse primer, 200mM of each
nucleotide (Promega), and 0.02 U/ml Taq polymerase
(Promega). PCR conditions were 35 cycles at 94 C˚ for 30
seconds, 55 C˚ for 30 seconds, and 72 C˚ for one minute. PCR
products were visualised on a 1% agarose gel and stained
with ethidium bromide. Band size and intensity were
measured with Kodak 1D software (Kodak, Rochester,
Minnesota, USA) version 3.5 by normalising against the
Figure 2 Mean relative expression of
(A) MUC1, (B) MUC2, (C) MUC3, (D)
MUC4, (E) MUC5AC, (F) MUC5B, and
(G) MUC6. The measurement of mucin
mRNA was performed by normalising
the band area and intensity with that of
b actin. Sq, squamous epithelium
(n = 32); BO, Barrett’s oesophagus
(n = 30); HGN, high grade
intraepithelial neoplasia (n = 6); and
ADC, adenocarcinoma (n = 15).
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housekeeping gene b actin, as described previously.17 Table 1
lists the primers used.
Protein crossblot
Aliquots of 20 mg of protein were loaded in the lanes of a
reverse line blotter (Immunetics, Cambridge, UK) on a PVDS
membrane (Roche, Mannheim, Germany). After one hour of
incubation at room temperature the samples were removed
and the membrane was blocked with 5% Protifar non-fat
milk (Nutricia, Cuijk, the Netherlands) in phosphate buffered
saline containing 0.1% Tween. The primary antibodies anti-
MUC2 (clone Ccp58; Novocastra, Newcastle, UK), anti-
MUC5AC (clone 45M1; Zymed, San Francisco, California,
USA), and anti-MUC6 (clone CLH5; Novocastra) were loaded
at an angle of 90˚ on to the protein samples. An alkaline
phosphatase labelled goat anti-mouse IgG antibody
(Southern Biotech Associates, Birmingham, Alabama, USA)
was used as conjugate and 0.18 mg/ml 5-bromo-4-dichloro-
3-indolyl phosphate (BCIP; Promega) and 0.35 mg/ml
nitroblue tetrazolium (NBT; Promega) in 0.1M Tris/HCl
(pH 9.5), 0.1M NaCl, and 5mM MgCl2 were added as
substrate. Immunohistochemical staining of gastric antrum
and colonic mucosa confirmed that the primary antibodies
detected the mature mucin protein in the case of MUC5AC
and MUC6, or a precursor peptide, in the case of MUC2.
Statistical analyses
RT-PCR data are presented as mean (SEM). Statistical
analyses were performed with the Mann-Whitney U test. A
p value , 0.05 was considered significant.
RESULTS
Mucin mRNA
Figure 1 shows the results of RT-PCR testing of different
mucins in squamous epithelium, BO, HGN, and ADC. Figure 2
shows the mean transcription levels of individual mucins
relative to the transcription of b actin in the same sample.
Overall, mucin transcription was low or absent in squamous
epithelium (relative transcription level, , 0.2), except for
MUC4 (relative transcription level, 1.1). Compared with
squamous epithelium, MUC4 was downregulated in BO
(relative transcription level, 0.62; p = 0.01), whereas the
other mucins tested were considerably upregulated in BO
(relative transcription level, . 0.4; p , 0.001). In HGN,
mucin transcription levels were similar to those seen in BO,
except for MUC4, which was significantly higher in HGN
than in BO (relative transcription levels 1.27 v 0.62;
p = 0.037). In most adenocarcinomas, the mucin mRNA
expression was lower than in BO without intraepithelial
neoplasia or with HGN. Amplification of residual chromoso-
mal DNA was not found. Sequencing and comparison with
previous published sequences confirmed the correct nature of
the mucin PCR products.
Mucin protein expression
Protein fractions from the same biopsies as the mRNA
fractions were analysed by protein crossblot to determine the
mucin patterns at the protein level (fig 3). Commercial
antibodies that recognise the denatured antigen were only
available for MUC2, MUC5AC, and MUC6. Crossblot analysis
revealed that in squamous epithelium MUC2 expression was
present in two of 32 patients, for MUC5AC in nine of 32
patients, and for MUC6 in two of 32 patients. In the BO
samples, MUC2 was expressed in 17 of 30 patients, MUC5AC
in 28 of 30 patients, and MUC6 in 26 of 30 patients. In HGN,
MUC6 was expressed in 15 of 30 samples, whereas expression
of MUC2 and MUC5AC was comparable to that seen in BO
(three of six and six of six, respectively). MUC5AC and MUC6
protein were found in nine of 15 and MUC2 protein in three
of 15 of the ADC samples (fig 4). Protein data were found to
correlate with the mRNA data.
Correlation between Bax and Bcl-2 mRNA and mucin
mRNA expression
The correlation between mucin mRNA expression and the
apoptosis markers Bax and Bcl-2 was determined by
calculating the ratio of proapoptotic Bax and antiapoptotic
Bcl-2 mRNA. The amounts of Bax and Bcl-2 mRNA were
determined by semiquantitative RT-PCR (fig 5). The
Bax : Bcl-2 ratio was increased in HGN compared with BO
(ratio 1.71 v 0.83; p = 0.04). In ADC, the ratio was lower
than in HGN (0.95), but this difference was not significant
(p = 0.22). The raised Bax : Bcl-2 ratio in HGN was
associated with an increase in MUC4 mRNA.
DISCUSSION
Changes in the expression pattern of mucins have been
associated with the development of early carcinomas of the
colon, gallbladder, and the respiratory tract.18–21 The expres-
sion pattern of mucins in oesophageal adenocarcinoma has
also been determined10 11 22; however, the pattern of mucin
expression in high grade intraepithelial neoplasia, the lesion
that precedes infiltrating adenocarcinoma, has not been
clarified. In our study, the transcription and expression of
various mucins in biopsies of oesophageal squamous epithe-
lium, BO, HGN, and ADC were determined. From each biopsy
sample, both RNA and protein were purified, thus minimis-
ing sample discordance between RNA and protein analysis.
Most mucins were upregulated in BO compared with
squamous epithelium. In adenocarcinomas, a greater variety,
with a trend towards lower mucin expression compared with
BO, was seen. Compared with non-dysplastic BO, HGN
contained higher amounts of MUC4 mRNA.
High expression of the secreted mucins MUC2, MUC5AC,
MUC5B, and MUC6 has been reported previously in BO,10 22
as has their downregulation in adenocarcinoma of the
oesophagus.10 11 In contrast to these reports, low amounts
of these mucins were found in some squamous epithelial
samples. Because RT-PCR is a very sensitive technique, these
low amounts could have escaped detection in immunohisto-
chemical studies.
However, the possibility that the squamous samples were
contaminated with intestinal glands or subepithelial proper
glands cannot be excluded. Adjacent biopsies were analysed
for the purity of the epithelium because approaches designed
for the extraction of mRNA from fixed tissue used for
histological analysis have not been validated for the
Anti-MUC2
b s b s b b b bhs s a a h
Anti-MUC5AC
Anti-MUC6
Figure 3 Representative example of protein crossblot. Protein samples
were spotted in lanes on a membrane. Primary antibodies were spotted
in lanes at an angle of 90˚ and were detected with an alkaline
phosphatase labelled secondary antibody. s, squamous epithelium; b,
Barrett’s oesophagus; h, high grade intraepithelial neoplasia; a,
adenocarcinoma.
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quantitative comparison of mRNA. Furthermore, the pre-
sence of the MUC2, MUC5AC, and MUC6 proteins in the
squamous epithelium could have been caused by reflux of
gastric mucous components, including these mucins.
Most reports describe high expression of MUC1 in
squamous epithelium and low expression in BO,10 11 23
whereas the opposite is shown in our present study. An
explanation for this could be that most studies used
unrelated squamous epithelium samples, whereas in our
study paired squamous/BO samples from a single patient
were used in which inflammation could have altered the
mucin pattern. However, the most striking result is the
upregulation of MUC4 in HGN compared with BO without
intraepithelial neoplasia. This has not been reported before.
Duodenogastro–oesophageal reflux has been implicated in
the development of BO and oesophageal adenocarcinoma.24
Recently, it was found that in particular bile salts and their
conjugates induce the transcription of MUC4 mRNA in
oesophageal cancer cells.25 This could explain the observed
increase of MUC4 in HGN.
‘‘The most striking result is the upregulation of MUC4 in
high grade intraepithelial neoplasia compared with
Barrett’s oesophagus without intraepithelial neoplasia’’
Increased MUC4 expression has also been found in other
early neoplastic lesions, such as early pancreatic carcinomas
and dysplastic cervical lesions.26 27 When produced in normal
quantities, MUC4 has been reported to function as a steric
barrier that limits the access of other cells and large
molecules to the epithelium, thereby protecting it from
damage.28 In contrast, overexpression of MUC4 disrupts cell–
cell and cell–matrix interactions, which could initiate the
dissociation of tumour cells from the primary tumour.29
Finally, overexpression of MUC4 may result in the masking
of tumour antigens, thereby effectively suppressing tumour
cell killing by cytotoxic lymphocytes.28 Because oesophageal
adenocarcinoma often metastasises at an early phase, loss of
cell adhesion probably occurs at an early stage of carcino-
genesis. Increased MUC4 expression could contribute to
the detachment of tumour cells from the primary adeno-
carcinoma.
MUC4 protein also acts as a ligand for the receptor tyrosine
kinase, Erb-B2, a protooncogene that is abnormally expressed
in the membranes of Barrett’s epithelium and associated
adenocarcinoma.30 31 The MUC4–Erb-B2 complex is involved
in the inhibition of apoptosis,32 thereby promoting tumour
growth. Strong suppression of apoptosis was seen in MUC4
overexpressing tumours in mice.16 In our study, the mRNA
levels of the apoptosis markers Bax and Bcl-2 were also
determined. Inhibition of apoptosis was not found in the
HGN samples with increased MUC4 expression. In contrast,
the Bax : Bcl-2 ratio was increased in HGN compared with
BO. This might indicate that MUC4 plays only a minor role in
the regulation of apoptosis in HGN in humans.
An increased apoptotic rate does not fit in with the model
of neoplastic progression.33 However, reduced Bcl-2 expres-
sion during the neoplastic progression of BO has been
reported before.34 A recent report described clear Bax and
Bcl-2 expression in both BO, HGN, and ADC, but results were
not quantitative.35 Other apoptotic proteins, such as the Fas
ligand and caspases, may have an antiapoptotic effect in BO
with HGN, to compensate for the proapoptotic Bax : Bcl-2
balance.
Figure 4 Protein crossblot analysis: percentage of samples positive for
(A) MUC2, (B) MUC5AC, and (C) MUC6. Sq, squamous epithelium
(n = 32); BO, Barrett’s oesophagus (n = 30); HGN, high grade
intraepithelial neoplasia (n = 6); and ADC, adenocarcinoma (n = 15).
Figure 5 Summary of the data on Bax : Bcl-2 ratios. The measurement
of Bax and Bcl-2 mRNA was performed by dividing the band area and
intensity of Bax by that of Bcl-2. Sq, squamous epithelium (n = 9); BO,
Barrett’s oesophagus (n = 8); HGN, high grade intraepithelial
neoplasia (n = 6); and ADC, adenocarcinoma (n = 4).
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In conclusion, the results of our study show that mucin
expression is altered in BO. Membrane bound mucin MUC4
is associated with the development of high grade intra-
epithelial neoplasia in BO, but not with a decrease in
apoptosis. This suggests a role for MUC4 as an early tumour
marker in BO. In combination with other tumour markers, it
could facilitate the early diagnosis of adenocarcinoma both in
vitro and in vivo. However, additional studies are necessary to
verify this hypothesis.
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Take home messages
N Mucin expression varies during the development of
oesophageal adenocarcinoma in Barrett’s oesophagus
(BO)
N Membrane bound mucin MUC4 is associated with the
development of high grade intraepithelial neoplasia in
BO and could serve as an early tumour marker in this
process, although additional studies are necessary to
verify this hypothesis
N In contrast to animal studies, upregulation of MUC4 in
high grade intraepithelial neoplasia is associated with
increased apoptosis, suggesting that MUC4 plays a
minor role in the regulation of apoptosis in BO
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